Drugs / rDEN3delta30/31-7164
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00831012 | Sep 2009 → Jun 2011 | dengue disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rDEN3delta30/31-7164 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00831012 ↗ |
| Modality | Vaccine | “A live attenuated, recombinant DEN3 candidate vaccine virus” NCT00831012 ↗ |
| Route | Subcutaneous | “subcutaneously in their deltoid” NCT00831012 ↗ |